Insider Trading & Ownership - Kolaja Carey OConnor

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kolaja Carey OConnor
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-06-15
Sale
2023-06-20
4:25 pm
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
2,500$28.24$70,60024,817
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-01
Option Award
2024-05-03
08:45 am
N/A
2034-04-30
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
38,458$055,019
(Direct)
View
2023-06-15
Exercise
2023-06-20
4:25 pm
N/A
2032-05-03
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
2,500$024,817
(Direct)
View
2023-06-15
Exercise
2023-06-20
4:25 pm
N/A
N/A
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
2,500$18.1224,817
(Direct)
View
2023-05-03
Option Award
2023-05-05
5:14 pm
N/A
2033-05-02
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
9,449$022,476
(Direct)
View
2022-05-04
Option Award(A)
2022-05-13
6:10 pm
N/A
2032-05-03
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
10,756$010,756
(Direct)
View
2022-05-04
Option Award
2022-05-06
6:19 pm
N/A
2032-05-03
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
17,402$024,370
(Direct)
View
2021-05-05
Option Award
2021-05-07
7:08 pm
N/A
2031-05-04
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
1,942$08,236
(Direct)
View
2021-03-01
Option Award
2021-03-02
8:17 pm
N/A
2031-02-28
Revance Therapeutics Inc.RVNCKolaja Carey OConnor
Director
17,711$017,711
(Direct)
View
(A) Indicate amendment filing.